SynthesisEuropean journal of medical research2025
The eye-mind connection: a systematic review of retinal biomarkers and ocular signatures in major psychiatric disorders.
Synthesis in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Seeing Through Feeling: Dynamic Interplay Between Emotion and Visual Perception.Brain sciences · 2026Review
- Associations between psychiatric disorders and medication use, and retinal occlusion: a large-scale retrospective cohort study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsychiatric disorders such as schizophrenia, bipolar disorder, major depression, and dementia are increasingly associated with specific ocular and retinal abnormalities. These associations may reflect shared neurovascular, inflammatory, and neurodegenerative mechanisms, yet findings remain scattered and understudied. This systematic review synthesizes existing evidence on ocular and retinal pathologies across major psychiatric conditions, highlighting common retinal biomarkers that may inform future screening strategies.
methodsFollowing PRISMA 2020 guidelines, a systematic search of PubMed, Scopus, Web of Science, and Embase was conducted. Meta-analysis was initially planned but deemed infeasible due to significant methodological and reporting heterogeneity among eligible studies. Therefore, a structured qualitative synthesis was performed, supported by visual mapping of cross-disorder associations.
resultsSeventeen studies met inclusion criteria, covering major psychiatric conditions including schizophrenia, bipolar disorder, depression, and dementia. Across these disorders, approximately three-quarters of schizophrenia studies (≈75%) reported retinal nerve fiber layer (RNFL) thinning, and two-thirds of dementia studies (≈67%) showed retinal vascular abnormalities or RNFL loss. Glaucoma and dry eye syndrome were the most frequently observed in mood disorders, whereas microvascular dropout was reported in optical coherence tomography angiography (OCT-A) analyses of depression and bipolar disorder. The heatmap visualization highlighted overlapping neuro-ophthalmic signatures, and retinal biomarker analysis identified RNFL thinning and microvascular dropout as potential shared indicators of disease burden.
conclusionThis review emphasizes the emerging evidence for retinal biomarkers as accessible correlates of neuropsychiatric pathology. Although quantitative synthesis was not feasible, the qualitative patterns highlight the need for large-scale, prospective, and biomarker-validation studies integrating ophthalmology and psychiatry. These findings underscore the clinical potential of the brain-retina axis in mental health diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.